De novo Fatty Acid Biosynthesis Contributes Significantly to Establishment of a Bioenergetically Favorable Environment for Vaccinia Virus Infection

PLoS Pathogens

Volumn 10, Issue 3, 2014, Pages

  Greseth, Matthew D ^a   Traktman, Paula ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARIC ACID; ACETYL COENZYME A CARBOXYLASE; CARNITINE PALMITOYLTRANSFERASE I; CERULENIN; ETOMOXIR; GLUTAMATE DEHYDROGENASE; GLUTAMINASE; MALONYL COENZYME A; METHIONINE; PALMITIC ACID; TRIMETAZIDINE; VIRUS DNA; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL FUNCTION; CITRIC ACID CYCLE; CONTROLLED STUDY; DNA REPLICATION; ELECTRON MICROSCOPY; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; IMMUNOFLUORESCENCE MICROSCOPY; LIFE CYCLE STAGE; METABOLISM; MITOCHONDRIAL DYNAMICS; NONHUMAN; OXYGEN CONSUMPTION; PALMITOYLATION; PHOSPHOLIPID SYNTHESIS; PROTEIN SYNTHESIS; PULSED FIELD GEL ELECTROPHORESIS; VACCINIA; VIRUS MORPHOGENESIS; VIRUS REPLICATION;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; ELECTROPHORESIS, GEL, PULSED-FIELD; FATTY ACIDS; HOST-PARASITE INTERACTIONS; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; PALMITATES; POXVIRIDAE INFECTIONS; VACCINIA VIRUS; VIRION; VIRUS ASSEMBLY;

EID: 84897450679     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004021     Document Type: Article

References (54)

1. Munger J, Bajad SU, Coller HA, Shenk T, Rabinowitz JD, (2006) Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog 2: e132.
2. Munger J, Bennett BD, Parikh A, Feng XJ, McArdle J, et al. (2008) Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat Biotechnol 26: 1179-1186.
3. Chambers JW, Maguire TG, Alwine JC, (2010) Glutamine metabolism is essential for human cytomegalovirus infection. J Virol 84: 1867-1873.
4. Liu H, Liu JY, Wu X, Zhang JT, (2010) Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker. Int j biochem mol bio 1: 68-89.
5. Spencer CM, Schafer XL, Moorman NJ, Munger J, (2011) Human cytomegalovirus induces the activity and expression of acetyl-coenzyme A carboxylase, a fatty acid biosynthetic enzyme whose inhibition attenuates viral replication. J Virol 85: 5814-5824.
6. Heaton NS, Perera R, Berger KL, Khadka S, LaCount DJ, et al. (2010) Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc Natl Acad Sci U S A 107: 17345-17350.
7. Oem JK, Jackel-Cram C, Li YP, Zhou Y, Zhong J, et al. (2008) Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2. J Gen Virol 89: 1225-1230.
8. Yang W, Hood BL, Chadwick SL, Liu S, Watkins SC, et al. (2008) Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production. Hepatology 48: 1396-1403.
9. Park CY, Jun HJ, Wakita T, Cheong JH, Hwang SB, (2009) Hepatitis C virus nonstructural 4B protein modulates sterol regulatory element-binding protein signaling via the AKT pathway. J Biol Chem 284: 9237-9246.
10. Nasheri N, Joyce M, Rouleau Y, Yang P, Yao S, et al. (2013) Modulation of fatty acid synthase enzyme activity and expression during hepatitis C virus replication. Chem Biol 20: 570-582.
11. Huang JT, Tseng CP, Liao MH, Lu SC, Yeh WZ, et al. (2013) Hepatitis C virus replication is modulated by the interaction of nonstructural protein NS5B and fatty acid synthase. J Virol 87: 4994-5004.
12. Mazzon M, Peters NE, Loenarz C, Krysztofinska EM, Ember SW, et al. (2013) A mechanism for induction of a hypoxic response by vaccinia virus. Proc Natl Acad Sci U S A 110: 12444-12449.
13. Punjabi A, Traktman P, (2005) Cell biological and functional characterization of the vaccinia virus F10 kinase: implications for the mechanism of virion morphogenesis. J Virol 79: 2171-2190.
14. Vock C, Gleissner M, Klapper M, Doring F, (2007) Identification of palmitate-regulated genes in HepG2 cells by applying microarray analysis. Biochim Biophys Acta 1770: 1283-1288.
15. Webb Y, Hermida-Matsumoto L, Resh MD, (2000) Inhibition of protein palmitoylation, raft localization, and T cell signaling by 2-bromopalmitate and polyunsaturated fatty acids. J Biol Chem 275: 261-270.
16. Thorp EB, Boscarino JA, Logan HL, Goletz JT, Gallagher TM, (2006) Palmitoylations on murine coronavirus spike proteins are essential for virion assembly and infectivity. J Virol 80: 1280-1289.
17. Ahearn IM, Tsai FD, Court H, Zhou M, Jennings BC, et al. (2011) FKBP12 binds to acylated H-ras and promotes depalmitoylation. Mol Cell 41: 173-185.
18. Tomoda H, Igarashi K, Cyong JC, Omura S, (1991) Evidence for an essential role of long chain acyl-CoA synthetase in animal cell proliferation. Inhibition of long chain acyl-CoA synthetase by triacsins caused inhibition of Raji cell proliferation. J Biol Chem 266: 4214-4219.
19. Cheung W, Gill M, Esposito A, Kaminski CF, Courousse N, et al. (2010) Rotaviruses associate with cellular lipid droplet components to replicate in viroplasms, and compounds disrupting or blocking lipid droplets inhibit viroplasm formation and viral replication. J Virol 84: 6782-6798.
20. Namatame I, Tomoda H, Arai H, Inoue K, Omura S, (1999) Complete inhibition of mouse macrophage-derived foam cell formation by triacsin C. J Biochem 125: 319-327.
21. Fujimoto T, Ohsaki Y, (2006) Cytoplasmic lipid droplets: rediscovery of an old structure as a unique platform. Ann N Y Acad Sci 1086: 104-115.
22. Fujimoto Y, Itabe H, Kinoshita T, Homma KJ, Onoduka J, et al. (2007) Involvement of ACSL in local synthesis of neutral lipids in cytoplasmic lipid droplets in human hepatocyte HuH7. J Lipid Res 48: 1280-1292.
23. Kim Y, George D, Prior AM, Prasain K, Hao S, et al. (2012) Novel triacsin C analogs as potential antivirals against rotavirus infections. Eur J Med Chem 50: 311-318.
24. Seltzer MJ, Bennett BD, Joshi AD, Gao P, Thomas AG, et al. (2010) Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. Cancer Res 70: 8981-8987.
25. Kantor PF, Lucien A, Kozak R, Lopaschuk GD, (2000) The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 86: 580-588.
26. Dranka BP, Benavides GA, Diers AR, Giordano S, Zelickson BR, et al. (2011) Assessing bioenergetic function in response to oxidative stress by metabolic profiling. Free Radic Biol Med 51: 1621-1635.
27. Pike LS, Smift AL, Croteau NJ, Ferrick DA, Wu M, (2011) Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim Biophys Acta 1807: 726-734.
28. Unger B, Traktman P, (2004) Vaccinia virus morphogenesis: A13 phosphoprotein is required for assembly of mature virions. J Virol 78: 8885-8901.
29. Traktman P, Caligiuri A, Jesty SA, Liu K, Sankar U, (1995) Temperature-sensitive mutants with lesions in the vaccinia virus F10 kinase undergo arrest at the earliest stage of virion morphogenesis. J Virol 69: 6581-6587.
30. Wang S, Shuman S, (1995) Vaccinia virus morphogenesis is blocked by temperature-sensitive mutations in the F10 gene, which encodes protein kinase 2. J Virol 69: 6376-6388.
31. Baldick CJ Jr, Moss B, (1987) Resistance of vaccinia virus to rifampicin conferred by a single nucleotide substitution near the predicted NH2 terminus of a gene encoding an Mr 62,000 polypeptide. Virology 156: 138-145.
32. Grimley PM, Rosenblum EN, Mims SJ, Moss B, (1970) Interruption by Rifampin of an early stage in vaccinia virus morphogenesis: accumulation of membranes which are precursors of virus envelopes. J Virol 6: 519-533.
33. Sodeik B, Griffiths G, Ericsson M, Moss B, Doms RW, (1994) Assembly of vaccinia virus: effects of rifampin on the intracellular distribution of viral protein p65. J Virol 68: 1103-1114.
34. Tartaglia J, Paoletti E, (1985) Physical mapping and DNA sequence analysis of the rifampicin resistance locus in vaccinia virus. Virology 147: 394-404.
35. Zhang Y, Moss B, (1992) Immature viral envelope formation is interrupted at the same stage by lac operator-mediated repression of the vaccinia virus D13L gene and by the drug rifampicin. Virology 187: 643-653.
36. Child SJ, Hruby DE, (1992) Evidence for multiple species of vaccinia virus-encoded palmitylated proteins. Virology 191: 262-271.
37. Grosenbach DW, Hansen SG, Hruby DE, (2000) Identification and analysis of vaccinia virus palmitylproteins. Virology 275: 193-206.
38. Chang CW, Li HC, Hsu CF, Chang CY, Lo SY, (2009) Increased ATP generation in the host cell is required for efficient vaccinia virus production. J Biomed Sci 16: 80.
39. Winder WW, Wilson HA, Hardie DG, Rasmussen BB, Hutber CA, et al. (1997) Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. J Appl Physiol (1985) 82: 219-225.
40. Moreau K, Dizin E, Ray H, Luquain C, Lefai E, et al. (2006) BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase. J Biol Chem 281: 3172-3181.
41. Kim CW, Moon YA, Park SW, Cheng D, Kwon HJ, et al. (2010) Induced polymerization of mammalian acetyl-CoA carboxylase by MIG12 provides a tertiary level of regulation of fatty acid synthesis. Proc Natl Acad Sci U S A 107: 9626-9631.
42. Knobloch M, Braun SM, Zurkirchen L, von SC, Zamboni N, et al. (2013) Metabolic control of adult neural stem cell activity by Fasn-dependent lipogenesis. Nature 493: 226-230.
43. Qi L, Heredia JE, Altarejos JY, Screaton R, Goebel N, et al. (2006) TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism. Science 312: 1763-1766.
44. Jin Q, Yuan LX, Boulbes D, Baek JM, Wang YN, et al. (2010) Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells. Breast Cancer Res 12: R96.
45. Yu J, Deng R, Zhu HH, Zhang SS, Zhu C, et al. (2013) Modulation of fatty acid synthase degradation by concerted action of p38 MAP kinase, E3 ligase COP1, and SH2-tyrosine phosphatase Shp2. J Biol Chem 288: 3823-3830.
46. Graner E, Tang D, Rossi S, Baron A, Migita T, et al. (2004) The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. Cancer Cell 5: 253-261.
47. Semenza GL, (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148: 399-408.
48. Yu Y, Clippinger AJ, Alwine JC, (2011) Viral effects on metabolism: changes in glucose and glutamine utilization during human cytomegalovirus infection. Trends Microbiol 19: 360-367.
49. Menendez JA, (2010) Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: Molecular mechanisms and therapeutic perspectives. Biochimica et Biophysica Acta (BBA)- Molecular and Cell Biology of Lipids 1801: 381-391.
50. Kuhajda FP, (2000) Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 16: 202-208.
51. Flavin R, Peluso S, Nguyen PL, Loda M, (2010) Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol 6: 551-562.
52. Butler EB, Zhao Y, Munoz-Pinedo C, Lu J, Tan M, (2013) Stalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistance. Cancer Res 73: 2709-2717.
53. Rochester SC, Traktman P, (1998) Characterization of the single-stranded DNA binding protein encoded by the vaccinia virus I3 gene. J Virol 72: 2917-2926.
54. Greseth MD, Boyle KA, Bluma MS, Unger B, Wiebe MS, et al. (2012) Molecular genetic and biochemical characterization of the vaccinia virus I3 protein, the replicative single-stranded DNA binding protein. J Virol 86: 6197-6209.